---
title: "Aspire Biopharma (ASBP.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ASBP.US/norm.md"
symbol: "ASBP.US"
name: "Aspire Biopharma"
parent: "https://longbridge.com/en/quote/ASBP.US.md"
datetime: "2026-03-04T00:13:59.793Z"
locales:
  - [en](https://longbridge.com/en/quote/ASBP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ASBP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ASBP.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ASBP.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ASBP.US/norm.md)


# Aspire Biopharma (ASBP.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.49 | -1.61 | -16.83 | -0.0671 | -0.3134 |
| ROE | 70.21% | 95.66% | 1501.62% | 252.29% | 481.20% |
| Revenue | 1941.00 | - | - | - | - |
| Net income | -1.85M | -1.98M | -15.94M | -738500.00 | -216269.00 |
| Operating income | -1.15M | -799890.00 | -1.43M | -640512.00 | -215256.00 |
| Gross margin | 45.54% | - | - | - | - |
| Net margin | -95337.09% | - | - | - | - |
| Profit quality | - | - | - | -133.56% | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.40M | 989422.00 | 1.97M | 147989.00 | 184041.00 |
| Leverage | -0.2096 | -0.1029 | -0.2827 | -0.0961 | -0.2296 |
| BVPS | -9.26 | -7.77 | -5.69 | -0.0035 | -0.0018 |
| Turnover | 0.0015 | - | - | - | - |
| Cash & STI | 1.95M | 206233.00 | 1.35M | 3633.00 | 16541.00 |
| Inv & Rec | 35437.00 | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | 6.68M | 8.27M | 5.42M | 1.26M | 836572.00 |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.10M | -1.14M | -1.75M | 479569.00 | -495540.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | 2.85M | 0.0000 | 3.09M | -492477.00 | 492477.00 |
| Free CF | 2.76M | -685421.00 | 14.45M | -88447.00 | -458387.00 |
| OCF coverage | -31.57% | - | -791.15% | - | - |
| Repaid & issued | 7.25M | 0.0000 | 3.05M | -492477.00 | 492477.00 |
| CapEx | - | - | - | - | - |